The effect of inhaled nitric oxide on dyspnea and exercise capacity in mild COPD

D. Phillips (Edmonton, Canada), A. Brotto (Edmonton, Canada), B. Ross (Edmonton, Canada), T. Bryan (Edmonton, Canada), E. Wong (Edmonton, Canada), S. Van Diepen (Edmonton, Canada), M. Stickland (Edmonton, Canada)

Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Session: Exercise physiopathology in various respiratory diseases
Session type: Oral Presentation
Number: 3572
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Phillips (Edmonton, Canada), A. Brotto (Edmonton, Canada), B. Ross (Edmonton, Canada), T. Bryan (Edmonton, Canada), E. Wong (Edmonton, Canada), S. Van Diepen (Edmonton, Canada), M. Stickland (Edmonton, Canada). The effect of inhaled nitric oxide on dyspnea and exercise capacity in mild COPD. 3572

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predicting performance of cough reflex sensitivity, exhaled nitric oxide (eNO) and bronchial responsiveness for efficacy of bronchodilator therapy on isolated chronic non-productive cough
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

The effect of inhaled nitric oxide on the cardiac performance in patients with hypoxic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003

Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004

Pulsed inhaled nitric oxide (iNO) improves exercise tolerance and shortness of breath (SOB) in severe COPD subjects with pulmonary hypertension (PH)
Source: International Congress 2018 – Advances in exercise physiopathology
Year: 2018




Exercise training and exhaled nitric oxide (eNO) in COPD patients of different severity
Source: Eur Respir J 2001; 18: Suppl. 33, 222s
Year: 2001

Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004

The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Predictors of efficacy of bronchodilator therapy for chronic non-productive cough: cough reflex sensitivity, exhaled nitric oxide, bronchial responsiveness?
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008


The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
Source: Eur Respir J 2010; 35: 72-78
Year: 2010



The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001

Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010

Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005

The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

The role of exhaled nitric oxide in the evaluation of chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 794s
Year: 2006

Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
Source: Eur Respir J 2002; 20: 841-845
Year: 2002